Article info
Clinical and epidemiological research
Extended report
Rituximab for IgG4-related disease: a prospective, open-label trial
- Correspondence to Dr John H Stone, Rheumatology Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA; jhstone{at}partners.org
Citation
Rituximab for IgG4-related disease: a prospective, open-label trial
Publication history
- Received September 10, 2014
- Revised December 26, 2014
- Accepted January 6, 2015
- First published February 9, 2015.
Online issue publication
October 31, 2019
Article Versions
- Previous version (8 February 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions